Levation Pharma

Levation Pharma, a pharmaceutical company focused on the development of new therapies in the ophthalmology and aesthetics fields. The company is developing LEV102, which is used to treat acquired blepharoptosis in adults. Acquired ptosis, or upper eyelid drooping, is a common condition associated with aging or underlying medical conditions. Patients may complain of impaired vision as well as cosmetically unpleasant eyes, making them appear aged and tired.